Terms: = Endocrine gland cancer AND PSA AND Prognosis
17 results:
1. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
[TBL] [Abstract] [Full Text] [Related]
2. Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up.
Lv L; Jiang Y; Yin S; Hu Y; Chen C; Ma W; Jiang S; Zhou P
Endocrine; 2019 Nov; 66(2):310-318. PubMed ID: 31368083
[TBL] [Abstract] [Full Text] [Related]
3. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
[TBL] [Abstract] [Full Text] [Related]
4. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer.
Liu F; Du F; Chen X
World J Surg Oncol; 2014 Nov; 12():333. PubMed ID: 25381564
[TBL] [Abstract] [Full Text] [Related]
5. [Metastasis in testis from prostate cancer].
Mortensen MA; Engvad B; Geertsen L; Svolgaard N; Lund L
Ugeskr Laeger; 2014 Mar; 176(13):. PubMed ID: 25349932
[TBL] [Abstract] [Full Text] [Related]
6. Solitary testicular metastasis from prostate cancer: a rare case of isolated recurrence after radical prostatectomy.
Janssen S; Bernhards J; Anastasiadis AG; Bruns F
Anticancer Res; 2010 May; 30(5):1747-9. PubMed ID: 20592373
[TBL] [Abstract] [Full Text] [Related]
7. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
[TBL] [Abstract] [Full Text] [Related]
8. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
[TBL] [Abstract] [Full Text] [Related]
9. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
[TBL] [Abstract] [Full Text] [Related]
10. Serotonin used as prognostic marker of urological tumors.
Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
[TBL] [Abstract] [Full Text] [Related]
11. [Significance of current bio- and molecular-markers in urological cancers].
Shimazui T; Akaza H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
[TBL] [Abstract] [Full Text] [Related]
13. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Canil CM; Tannock IF
Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
[TBL] [Abstract] [Full Text] [Related]
14. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
[TBL] [Abstract] [Full Text] [Related]
15. Prostate specific antigen (psa) in breast and ovarian cancer.
Kucera E; Kainz C; Tempfer C; Zeillinger R; Koelbl H; Sliutz G
Anticancer Res; 1997; 17(6D):4735-7. PubMed ID: 9494598
[TBL] [Abstract] [Full Text] [Related]
16. Nonprostatic sources of prostate-specific antigen.
Diamandis EP; Yu H
Urol Clin North Am; 1997 May; 24(2):275-82. PubMed ID: 9126224
[TBL] [Abstract] [Full Text] [Related]
17. Marker determination for response monitoring: radiotherapy and disappearance curves.
Becciolini A; Porciani S; Lanini A
Int J Biol Markers; 1994; 9(1):38-42. PubMed ID: 7519652
[TBL] [Abstract] [Full Text] [Related]